UAE Continuous Glucose Monitoring (CGM) Market - Strategic Insights and Forecasts (2026-2031)

The UAE Continuous Glucose Monitoring (CGM) market is forecast for significant expansion, projected to grow at a Compound Annual Growth Rate (CAGR) of 12.5% during the 2026-2031 period. This growth will see the market's value increase from USD 0.008 billion in 2026 to an estimated USD 0.015 billion by 2031.

Key drivers for the UAE CGM market include growing awareness of diabetes preventative care, the introduction of new products, and supportive government efforts. Additionally, the increasing prevalence of Type 1 and Type 2 diabetes, fueled by unhealthy lifestyles and other risk factors, significantly boosts the demand for CGM devices.

Continuous Glucose Monitoring (CGM) systems in the UAE have broad applications across various healthcare settings. These include hospital ICUs, diagnostic centers, and clinics. The technology is also applicable for all age groups and across different geographical locations, emphasizing its widespread utility in diabetes management.

The increasing prevalence of diabetes in the UAE is a major catalyst for the CGM market, driving significant demand for monitoring devices. The World Diabetes Federation estimates that the number of diabetics in the UAE will rise from 0.99 million in 2021 to 1.32 million by 2045. This surge in diabetic patients directly correlates with an increased need for continuous glucose monitoring systems for better disease management.

Technological advancements are a crucial growth driver for the UAE CGM market, as global players are actively investing in research and development to create novel and cutting-edge devices. These innovations enhance the convenience and effectiveness of monitoring blood glucose levels, leading to increased adoption among patients with Type 1 and Type 2 diabetes.

Government initiatives in the UAE are instrumental in fostering the CGM market by promoting diabetes preventative care and encouraging healthier lifestyles. These efforts also support local manufacturers and invite international companies in the healthcare sector, creating a robust environment for market expansion and increasing public awareness about diabetes management and CGM technology.